Senate bill S1096-119
Judiciary Committee
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
• Last activity on Mar 24, 2025
• Introduced Mar 24, 2025
• By Sen. Klobuchar, Amy [D-MN]